Pfizer (PFE) stock in focus as the company with Astellas Pharma (ALPMF) (ALPMY) announce a Phase 3 trial win for their ...

Creation Healthcare analysed over 80,000 posts on X (formerly Twitter) referencing prostate cancer between January 2024 and January 2025 - authored by more than 17,000 individual HCPs.

New medicine to treat patients with non-metastatic castration-resistant prostate cancer (nmCRPC) is available in China to save those at high risk of developing metastases.

You may know that prostate cancer is one of the most common cancer types in men. The good news is that there are many treatment and management options, even if the cancer is caught at a later stage.

Genes. Men with certain inherited gene changes are at higher risk for prostate cancer. But only a small amount of prostate cancers are strongly linked to gene changes. What are your risk factors? Talk ...